跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Toujeo - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Toujeo
Approved
STANDARD
Toujeo
Sanofi-Aventis Deutschland GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cb3a67a71d6f599b
Company
Sanofi-Aventis Deutschland GmbH
Type
Standard
Approval Details
Approval Id
cb3a67a71d6f599b
Drug Approval Philippines Name
Toujeo
Product Name
Toujeo
Registration Number
BRP-055
Brand Name
Toujeo
Generic Name
Insulin Glargine
Dosage Form
Powder For Oral Suspension Solution for Injection (SC)
Dosage Strength
300 Units (equivalent to 10.91 mg)/mL
Manufacturer
Sanofi-Aventis Deutschland GmbH
Importer
Sanofi-Aventis Philippines, Inc.
Company Detail Path
/organization/sanofi-aventis-deutschland-gmbh
Issuance Date
27 June 2022
Expiry Date
23 June 2026
Pharmacologic Category
Antidiabetics
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cb3a67a71d6f599b
Type
Standard
Back to Philippines FDA Approvals